Drug General Information
Drug ID	D0L3BQ
Former ID	DNC011615
Drug Name	N-Hydroxy-4-isobutyl-benzamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[532087]
Structure		Download 2D MOL 3D MOL
Formula	C11H15NO2
Canonical SMILES	CC(C)CC1=CC=C(C=C1)C(=O)NO
InChI	1S/C11H15NO2/c1-8(2)7-9-3-5-10(6-4-9)11(13)12-14/h3-6,8,14H,7H2,1-2H3,(H,12,13)
InChIKey	ACMIPAPWWYGZNO-UHFFFAOYSA-N
PubChem Compound ID	20771934
Target and Pathway
Target(s)	Arachidonate 5-lipoxygenase	Target Info	Inhibitor	[532087]
BioCyc Pathway	Aspirin-triggered lipoxin biosynthesis
	Resolvin D biosynthesis
	Leukotriene biosynthesis
	Lipoxin biosynthesis
	Aspirin triggered resolvin D biosynthesis
	Aspirin triggered resolvin E biosynthesis
KEGG Pathway	Arachidonic acid metabolism
	Metabolic pathways
	Serotonergic synapse
	Ovarian steroidogenesis
	Toxoplasmosis
NetPath Pathway	IL4 Signaling Pathway
PathWhiz Pathway	Arachidonic Acid Metabolism
WikiPathways	Vitamin D Receptor Pathway
	Arachidonic acid metabolism
	Eicosanoid Synthesis
	Selenium Micronutrient Network
References
Ref 532087	J Med Chem. 1990 Mar;33(3):992-8.Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships.
Ref 532087	J Med Chem. 1990 Mar;33(3):992-8.Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.